N/A N=69 Randomized Single-blind Other

A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients

Cirrhosis, Liver · Portal Hypertension · Ascites Hepatic

Bottom Line

View on ClinicalTrials.gov: NCT05928624 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2025

Primary outcome: Primary: Change in Mean Arterial Pressure — 0.5; 1 mmHg

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Withings Home Blood Pressure Device and Scale (Device); Standard of Care (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of California, San Francisco
Primary completion: Jul 2024

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Mean Arterial Pressure	0.5; 1	—
SECONDARY Change in Ascites Burden	6.1; 4.7	—

Summary

This is a randomized single-blind feasibility trial to test the utilization of home blood pressure devices to improve the clinical management of decompensated cirrhosis patients.

Eligibility Criteria

Inclusion Criteria

Patients will need to have decompensated cirrhosis defined as a Child Pugh Score ≥ 7

Exclusion Criteria

None

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05928624). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.